PRE 14A

PRELIMINARY PROXY STATEMENT

Company: TG THERAPEUTICS, INC.
Filed: March 5, 2012
Period of Report: March 5, 2012
Accession Number: 0001144204-12-012960

View Document ↗ View on SEC.gov ↗